QQ客服 官方微博 反馈留言

浏览/检索结果: 共19条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+advanced breast cancer in BOLERO-1 期刊论文 BREAST CANCER RESEARCH, 2017, 卷号: 19 作者:  Toi, Masakazu;  Shao, Zhimin;  Hurvitz, Sara;  Tseng, Ling-Ming;  Zhang, Qingyuan 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 Advanced breast cancer  BOLERO-1  Everolimus  HER2  Metastatic breast cancer  Asian   Visible-light-induced synthesis of polymers with versatile end groups mediated by organocobalt complexes 期刊论文 POLYMER CHEMISTRY, 2017 Liu, Xu; Tian, Lei; Wu, Zhenqiang; Zhao, Xianyuan; Wang, Zikuan; Yu, Donggeng; Fu, Xuefeng 收藏  |  浏览/下载：8/0  |  提交时间：2017/12/03 LIVING RADICAL POLYMERIZATION  FRAGMENTATION CHAIN TRANSFER  RAFT POLYMERIZATION  AMBIENT-TEMPERATURE  COBALT PORPHYRINS  ELECTRON-TRANSFER  CLICK CHEMISTRY  VINYL-ACETATE  COPOLYMERS  FUNCTIONALIZATION   Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+advanced breast cancer in BOLERO-1 期刊论文 2017, 卷号: 19, 期号: 1, 页码: 47 作者:  Toi Masakazu;  Shao Zhimin;  Hurvitz Sara;  Tseng Ling-Ming;  Zhang Qingyuan 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Advanced breast cancer  BOLERO-1  Everolimus  HER2  Metastatic breast cancer  Asian   Outcomes of re-treatment with first-line Trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant Trastuzumab: A prospective multicenter study 期刊论文 ONCOTARGET, 2016, 卷号: 7, 期号: 31 作者:  Xu, Binghe;  Hu, Xichun;  Zheng, Hong;  Wang, Xiaojia;  Zhang, Qingyuan 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/06 trastuzumab  human epidermal growth factor receptor 2 (HER2)  metastatic breast cancer  (Neo)adjuvant trastuzumab  relapse  re-treatment   Outcomes of re-treatment with first-line trastuzumab plus taxane in patients (pts) with metastatic breast cancer (mBC) who relapsed after (neo)adjuvant trastuzumab: A prospective multicenter study. 期刊论文 2016, 卷号: 34, 期号: 15 作者:  Xu, Binghe;  Hu, Xi-Chun;  Zheng, Hong;  Wang, Xiaojia;  Zhang, Qingyuan 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04 Outcomes of re-treatment with first-line Trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant Trastuzumab: A prospective multicenter study 期刊论文 2016, 卷号: 7, 期号: 31, 页码: 50643-50655 作者:  Xu, Binghe;  Hu, Xichun;  Zheng, Hong;  Wang, Xiaojia;  Zhang, Qingyuan 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 trastuzumab  human epidermal growth factor receptor 2 (HER2)  metastatic breast cancer  (Neo)adjuvant trastuzumab  relapse  re-treatment   Outcomes of re-treatment with first-line trastuzumab plus taxane in patients (pts) with metastatic breast cancer (mBC) who relapsed after (neo)adjuvant trastuzumab: A prospective multicenter study. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Xu, Binghe;  Hu, Xi-Chun;  Zheng, Hong;  Wang, Xiaojia;  Zhang, Qingyuan 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/04 National consensus in China on diagnosis and treatment of patients with advanced breast cancer 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2015, 卷号: 4, 期号: 5 作者:  Xu, Binghe;  Hu, Xichun;  Jiang, Zefei;  Li, Huiping;  Chen, Jiayi 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/13 Advanced breast cancer (ABC)  consensus  national  China   Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+advanced breast cancer: BOLERO-1 会议论文 作者:  Hurvitz, Sara A.;  Andre, Fabrice;  Jiang, Zefei;  Shao, Zhimin;  Neciosup, Silvia P. 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/19 Gemcitabine with cisplatin or paclitaxel in metastatic triple-negative breast cancer 会议论文 作者:  Hu, Xichun;  Xu, Binghe;  Cai, Li;  Wang, Zhonghua;  Wang, Biyun 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19